C O R R E S P O N D E N C E

Tomography-Guided Customized CXL
Cassagne et al. should be congratulated for their work on customized corneal cross-linking (CXL) in the May 2017 issue. 1 This novel technique has the potential to replace the standard protocol, and that is why we need a clear and contradiction-free presentation of parameters and results. However, the study has some flaws that need to be discussed.
First, the maximally used radiant exposure was 15 J/cm², which clearly exceeds the official exposure limit of 1 J/cm² as published by the International Commission on Non-Ionizing Radiation Protection. 2 Even assuming an absorption of the ultraviolet light by riboflavin, which has been reported to be maximally 90%, 3, 4 the energy load for intraocular structures is still substantially too high.
Second, this is by far not the first report of customized CXL. Our group presented nearly identical results already at the CXL Expert Meeting 2014 and the ESCRS 2015 meeting, and published in the American Journal of Ophthalmology in March 2016. 5 Other groups have published similar results regarding customized CXL. 6 Third, the presentation of the technique of ultraviolet application is contradictive: on page 291, it reads "superimposed concentric circular zones," but Figure  1 presents sectorial areas. Which customization was really used?
Finally, the title itself includes two misnomers: "topography-guided" and "collagen cross-linking." Because the authors centered the treatment on the posterior elevation obtained by the Oculyzer, the technique presented would be better characterized as "tomography-guided." Since 2013, we know that the CXL procedure established additional chemical bonds not only within the collagen molecules of the cornea but also well (and maybe even more important) in the interfibrillar space between proteoglycans forming bridges between the collagen fibers. 7 When using the term "collagen cross-linking," do the authors really refer only to the new chemical bonds within the collagen molecule or to the entire CXL process?
Reply
We agree that this exciting new technology has the potential to significantly alter the standard treatment approach for corneal cross-linking, and thank Seiler et al. for their comments on our article. 1 Although the International Commission on NonIonizing Radiation Protection guidelines do recommend a limit of 1 J/cm 2 , the purpose of the guidelines is to establish exposure limits for laser radiation, and they explicitly do not apply to "deliberate exposure as an integral part of medical treatment." The cross-linking device used in this study applies radiation with a non-laser light emitting diode (LED) for the purposes of medical treatment, so the International Commission on Non-Ionizing Radiation Protection guidelines do not apply in this case. Further, in our study, we saw no adverse impact on the intraocular surfaces, including the crystalline lens or retina.
We apologize for overlooking the fact that Seiler et al. were the first to publish on this new customized corneal cross-linking procedure in 2016. Nevertheless, we would like to highlight that at the time of submission our work was the first to deal with the biological aspect regarding demarcation line and confocal microcopy nerve and cell densities.
Regarding the description of the ultraviolet application technique, please allow us to clarify. In our study, we applied sectorial areas that were always part of circular treatment zones. The extent of these segments was determined based on the extent of the cone, ranging from partial segments to full circular treatment zones. The most important parameter is that these ar-
